L 775606
Latest Information Update: 23 Jan 2008
Price :
$50 *
At a glance
- Originator Merck Sharp & Dohme
- Class Antimigraines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine